SEARCH

SEARCH BY CITATION

References

  • 1
    World Health Organization. Prevention and control of non-communicable diseases – Report of the Secretary-General. World Health Organization 2011; 118. http://www.un.org/ga/search/view_doc.asp?symbol=A/66/83&Lang=E. Accessed June 26, 2011.
  • 2
    Beaglehole R, Bonita R, Alleyne G, et al. UN high-level meeting on non-communicable diseases: addressing four questions. Lancet. 2011 ;378:449–455.
  • 3
    World Health Organization. Global Status Report on Noncommunicable Diseases 2010. Geneva: WHO; 2011.
  • 4
    World Health Organization. Draft outcome document of the high-level meeting on the prevention and control of non-communicable diseases. World Health Organization 2011;18. http://www.who.int/nmh/events/2011/introduction_doc.pdf. Accessed June 26, 2011.
  • 5
    Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377:14381447.
  • 6
    The NCD Alliance. Proposed outcomes document for the United Nations high-level summit on non-communicable diseases. The NCD Alliance 2011. http://www.ncdalliance.org. Accessed June 10, 2011.
  • 7
    The NCD Alliance. NCD alliance plan for the United Nations summit on non-communicable diseases. NCD Alliance 2010. http://www.idf.org/webdata/NCD-Alliance-Plan.pdf. Accessed June 28, 2011.
  • 8
    World Health Organization. 2008–2013 Action plan for the global strategy for the prevention and control of noncommunicable diseases. World Health Organization 2008. http://www.who.int/nmh/publications/ncd_action_plan_en.pdf. Accessed June 28, 2011.
  • 9
    Mbanya JC, Squire SB, Cazap E, et al. Mobilising the world for chronic NCDs. Lancet. 2011;377:536537.
  • 10
    Danaei G, Finucane MM, Lin JK, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet. 2011;377:568577.
  • 11
    Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217223.
  • 12
    Lawes CM, Vander HS, Law MR, et al. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens. 2006;24:423430.
  • 13
    World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva: World Health Organization; 2009.
  • 14
    World Health Organization. Preventing Chronic Diseases : A Vital Investment. Geneva: World Health Organization; 2005.
  • 15
    Leeder S, Raymond S, Greenberg H, et al. A Race Against Time: The Challenge of Cardiovascular Disease in Developing Countries. New York, NY: Trustees of Columbia University; 2004.
  • 16
    Perry HM Jr, Miller JP, Fornoff JR, et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension. 1995;1:587594.
  • 17
    Rodgers A, Lawes CMM, Gaziano T, et al. The growing burden of risk from high blood pressure, cholesterol, and bodyweight: the burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract. 2011;118:c269c277.
  • 18
    Hossain MP, Goyder EC, Rigby JE, et al. CKD and poverty: a growing global challenge. Am J Kidney Dis. 2009;53:166174.
  • 19
    Nugent RA, Fathima SF, Feigl AB, et al. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract. 2011;118:c269c277.
  • 20
    Gaziano TA, Bitton A, Anand S, et al. The global cost of nonoptimal blood pressure. J Hypertens. 2009;27:14721477.
  • 21
    Mensah GA, Bakris G. Treatment and control of high blood pressure in adults. Cardiol Clin. 2010;28:609622.
  • 22
    Singh M, Mensah GA, Bakris G. Pathogenesis and clinical physiology of hypertension. Cardiol Clin. 2010;28:545559.
  • 23
    World Health Organization. WHO CVD-Risk Management Package for Low – and Medium-Resource Settings. Geneva: World Health Organization; 2002.
  • 24
    Mason JO, McGinnis JM. “Healthy People 2000”: an overview of the national health promotion and disease prevention objectives. Public Health Rep. 1990;105:441446.
  • 25
    Asaria P, Chisholm D, Mathers C, et al. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007;370:20442053.
  • 26
    Bakris G, Hill M, Mancia G, et al. Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action. J Hum Hypertens. 2008;22:6370.
  • 27
    Bryant JH, Velji A. Global health and the role of universities in the twenty-first century. Infect Dis Clin North Am. 2011;25:311321.
  • 28
    Paradis G, Chiolero A. The cardiovascular and chronic diseases epidemic in low- and middle-income countries: a global health challenge. J Am Coll Cardiol. 2011;57:17751777.
  • 29
    Yach D, Khan M, Bradley D, et al. The role and challenges of the food industry in addressing chronic disease. Global Health. 2010;6:10.
  • 30
    PepsiCo. Performance with purpose: the promise of PepsiCo: 2009 annual report. http://www.pepsico.com/annual09/downloads/PEPSICO_ANNUAL_REPORT2009_8MB.pdf. Accessed May 10, 2010.
  • 31
    The global alliance for chronic diseases. Lancet. 2009;373:2084.
  • 32
    Daar AS, Nabel EG, Pramming SK, et al. The global alliance for chronic diseases. Science. 2009;324:1642.